{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:12:00Z","timestamp":1792026720012,"version":"4.4.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009655","name":"Sunovion","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009655","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.schres.2019.10.008","type":"journal-article","created":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T01:23:58Z","timestamp":1573003438000},"page":"314-321","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["The effect of high vs. low dose lurasidone on eye movement biomarkers of prefrontal abilities in treatment-resistant schizophrenia"],"prefix":"10.1016","volume":"215","author":[{"given":"Tatiana","family":"Karpouzian-Rogers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Stocks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert Y.","family":"Meltzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James L.","family":"Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2019.10.008_bib1","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2000"},{"issue":"1","key":"10.1016\/j.schres.2019.10.008_bib2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00213-014-3649-4","article-title":"Pharmacogenetic associations of the type-3 metabotropic glutamate receptor (GRM3) gene with working memory and clinical symptom response to antipsychotics in first-episode schizophrenia","volume":"232","author":"Bishop","year":"2015","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.schres.2019.10.008_bib3","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1176\/jnp.14.4.454","article-title":"Differential effects of olanzapine and risperidone on cognition in schizophrenia? A saccadic eye movement study","volume":"14","author":"Broerse","year":"2002","journal-title":"J.\u00a0Neuropsychiatry Clin. Neurosci."},{"issue":"4","key":"10.1016\/j.schres.2019.10.008_bib5","first-page":"449","article-title":"Improved antisaccade performance with risperidone in schizophrenia","volume":"72","author":"Burke","year":"2002","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"issue":"5460","key":"10.1016\/j.schres.2019.10.008_bib6","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1126\/science.287.5460.2020","article-title":"Reversal of antipsychotic-induced working memory deficits by short-term dopamine D1 receptor stimulation","volume":"287","author":"Castner","year":"2000","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.schres.2019.10.008_bib7","doi-asserted-by":"crossref","first-page":"451","DOI":"10.4088\/JCP.v64n0416","article-title":"Clozapine in treatment-resistant patients with schizophrenia, schizoaffective disorder, or psychotic bipolar disorder: a naturalistic 48-month follow-up study","volume":"64","author":"Ciapparelli","year":"2003","journal-title":"J.\u00a0Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2019.10.008_bib71","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1742-1241.2010.02587.x","article-title":"Lurasidone for schizophrenia: a review of the efficacy and safety profile for this newly approved second-generation antipsychotic","volume":"65","author":"Citrome","year":"2011","journal-title":"International journal of clinical practice"},{"issue":"1718","key":"10.1016\/j.schres.2019.10.008_bib8","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2016.0192","article-title":"Mechanisms of saccade suppression revealed in the anti-saccade task","volume":"372","author":"Coe","year":"2017","journal-title":"Phil. Trans. R. Soc. B"},{"issue":"3","key":"10.1016\/j.schres.2019.10.008_bib9","first-page":"511","article-title":"Treatment-resistant schizophrenia","volume":"30","author":"Elkis","year":"2007","journal-title":"Psychiatr. Clin."},{"issue":"4","key":"10.1016\/j.schres.2019.10.008_bib10","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2174\/1570159033477017","article-title":"Pharmacological studies of smooth pursuit and antisaccade eye movements in schizophrenia: current status and directions for future research","volume":"1","author":"Ettinger","year":"2003","journal-title":"Curr. Neuropharmacol."},{"issue":"9","key":"10.1016\/j.schres.2019.10.008_bib11","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0028-3932(98)00020-7","article-title":"The antisaccade: a review of basic research and clinical studies","volume":"36","author":"Everling","year":"1998","journal-title":"Neuropsychologia"},{"issue":"7","key":"10.1016\/j.schres.2019.10.008_bib12","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1523\/JNEUROSCI.19-07-02740.1999","article-title":"Role of primate superior colliculus in preparation and execution of anti-saccades and pro-saccades","volume":"19","author":"Everling","year":"1999","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.schres.2019.10.008_bib13","series-title":"Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Clinical Trials Version (SCID-CT)","author":"First","year":"2007"},{"issue":"2","key":"10.1016\/j.schres.2019.10.008_bib15","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1152\/jn.1989.61.2.331","article-title":"Mnemonic coding of visual space in the monkey\u2019s dorsolateral prefrontal cortex","volume":"61","author":"Funahashi","year":"1989","journal-title":"J.\u00a0Neurophysiol."},{"issue":"6448","key":"10.1016\/j.schres.2019.10.008_bib16","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/365753a0","article-title":"Prefrontal neuronal activity in rhesus monkeys performing a delayed anti-saccade task","volume":"365","author":"Funahashi","year":"1993","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.schres.2019.10.008_bib17","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev.ne.11.030188.001033","article-title":"Topography of cognition: parallel distributed networks in primate association cortex","volume":"11","author":"Goldman-Rakic","year":"1988","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.schres.2019.10.008_bib20","first-page":"534","article-title":"Abnormal involuntary movement scale (AIMS)","volume":"338","author":"Guy","year":"1976","journal-title":"ECDEU Assess Man. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.schres.2019.10.008_bib21","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1017\/S0033291705006756","article-title":"Longitudinal studies of antisaccades in antipsychotic-naive first-episode schizophrenia","volume":"36","author":"Harris","year":"2006","journal-title":"Psychol. Med."},{"issue":"1","key":"10.1016\/j.schres.2019.10.008_bib22","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.schres.2011.01.004","article-title":"Performance and interview-based assessments of cognitive change in a randomized, double-blind comparison of lurasidone vs. ziprasidone","volume":"127","author":"Harvey","year":"2011","journal-title":"Schizophr. Res."},{"issue":"11","key":"10.1016\/j.schres.2019.10.008_bib23","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.euroneuro.2013.08.003","article-title":"Effect of lurasidone on neurocognitive performance in patients with schizophrenia: a short-term placebo-and active-controlled study followed by a 6-month double-blind extension","volume":"23","author":"Harvey","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.schres.2019.10.008_bib24","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.schres.2015.06.008","article-title":"Effect of lurasidone dose on cognition in patients with schizophrenia: post-hoc analysis of a long-term, double-blind continuation study","volume":"166","author":"Harvey","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2019.10.008_bib25","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bbr.2013.01.026","article-title":"The role of 5-HT7 receptor antagonism in the amelioration of MK-801-induced learning and memory deficits by the novel atypical antipsychotic drug lurasidone","volume":"244","author":"Horisawa","year":"2013","journal-title":"Behav. Brain Res."},{"issue":"3","key":"10.1016\/j.schres.2019.10.008_bib26","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1469-8986.2006.00403.x","article-title":"The antisaccade task as a research tool in psychopathology: a critical review","volume":"43","author":"Hutton","year":"2006","journal-title":"Psychophysiology"},{"key":"10.1016\/j.schres.2019.10.008_bib27","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":"Clozapine for the treatment-resistant","volume":"45","author":"Kane","year":"1988","journal-title":"Arch. Gen. Psychiatr."},{"issue":"1","key":"10.1016\/j.schres.2019.10.008_bib28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0165-1781(97)00126-1","article-title":"Saccadic eye movements in schizophrenic patients","volume":"77","author":"Karoumi","year":"1998","journal-title":"Psychiatry Res."},{"issue":"2","key":"10.1016\/j.schres.2019.10.008_bib29","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"issue":"5","key":"10.1016\/j.schres.2019.10.008_bib30","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0896-6273(04)00047-9","article-title":"Functional magnetic resonance imaging of macaque monkeys performing visually guided saccade tasks: comparison of cortical eye fields with humans","volume":"41","author":"Koyama","year":"2004","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.schres.2019.10.008_bib31","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0920-9964(97)00137-0","article-title":"Spatial accuracy of primary and secondary memory-guided saccades in schizophrenic patients","volume":"30","author":"Krappmann","year":"1998","journal-title":"Schizophr. Res."},{"issue":"6162","key":"10.1016\/j.schres.2019.10.008_bib32","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/332357a0","article-title":"Population coding of saccadic eye movements by neurons in the superior colliculus","volume":"332","author":"Lee","year":"1988","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.schres.2019.10.008_bib33","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/brain\/awh035","article-title":"Using saccades as a research tool in the clinical neurosciences","volume":"127","author":"Leigh","year":"2004","journal-title":"Brain"},{"issue":"9896","key":"10.1016\/j.schres.2019.10.008_bib34","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","article-title":"Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis","volume":"382","author":"Leucht","year":"2013","journal-title":"The Lancet"},{"issue":"2","key":"10.1016\/j.schres.2019.10.008_bib35","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/schbul\/sbu001","article-title":"Dose equivalents for second-generation antipsychotics: the minimum effective dose method","volume":"40","author":"Leucht","year":"2014","journal-title":"Schizophr. Bull."},{"issue":"6","key":"10.1016\/j.schres.2019.10.008_bib37","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.euroneuro.2011.12.008","article-title":"Antipsychotic medication and prefrontal cortex activation: a review of neuroimaging findings","volume":"22","author":"Liemburg","year":"2012","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.schres.2019.10.008_bib38","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1002\/1097-0258(20000715)19:13<1793::AID-SIM482>3.0.CO;2-Q","article-title":"Modeling covariance structure in the analysis of repeated measures data","volume":"19","author":"Little","year":"2000","journal-title":"Satis. Med."},{"issue":"1","key":"10.1016\/j.schres.2019.10.008_bib39","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.schres.2013.01.009","article-title":"Efficacy and safety of lurasidone 80 mg\/day and 160 mg\/day in the treatment of schizophrenia: a randomized, double-blind, placebo-and active-controlled trial","volume":"145","author":"Loebel","year":"2013","journal-title":"Schizophr. Res."},{"issue":"5","key":"10.1016\/j.schres.2019.10.008_bib40","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1017\/S0033291798007132","article-title":"Saccadic and attentional abnormalities in patients with schizophrenia","volume":"28","author":"Maruff","year":"1998","journal-title":"Psychol. Med."},{"issue":"2","key":"10.1016\/j.schres.2019.10.008_bib41","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000119294","article-title":"Ocular-motor delayed-response task performance among schizophrenia patients","volume":"34","author":"McDowell","year":"1996","journal-title":"Neuropsychobiology"},{"issue":"1","key":"10.1016\/j.schres.2019.10.008_bib42","first-page":"153","article-title":"Ocular motor delayed-response task performance among patients with schizophrenia and their biological relatives","volume":"38","author":"McDowell","year":"2001","journal-title":"Psychophysiology"},{"issue":"1","key":"10.1016\/j.schres.2019.10.008_bib44","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.coph.2011.02.007","article-title":"The role of serotonin receptors in the action of atypical antipsychotic drugs","volume":"11","author":"Meltzer","year":"2011","journal-title":"Curr. Opin. Pharmacol."},{"issue":"2","key":"10.1016\/j.schres.2019.10.008_bib45","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4088\/JCP.v69n0214","article-title":"A\u00a0randomized, double-blind comparison of clozapine and high-dose olanzapine in treatment-resistant patients with schizophrenia","volume":"69","author":"Meltzer","year":"2008","journal-title":"J.\u00a0Clin. Psychiatry"},{"issue":"9","key":"10.1016\/j.schres.2019.10.008_bib46","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1176\/appi.ajp.2011.10060907","article-title":"Lurasidone in the treatment of schizophrenia: a randomized, double-blind, placebo-and olanzapine-controlled study","volume":"168","author":"Meltzer","year":"2011","journal-title":"Am. J. Psychiatry"},{"issue":"8","key":"10.1016\/j.schres.2019.10.008_bib47","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.2174\/138920112800784880","article-title":"Serotonin receptors as targets for drugs useful to treat psychosis and cognitive impairment in schizophrenia","volume":"13","author":"Meltzer","year":"2012","journal-title":"Curr. Pharmaceut. Biotechnol."},{"issue":"4","key":"10.1016\/j.schres.2019.10.008_bib48","first-page":"323","article-title":"Development, reliability and acceptability of a new version of the DSM-IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social funtioning","volume":"101","author":"Morosini","year":"2000","journal-title":"Acta Psychiatr. Scand."},{"issue":"3","key":"10.1016\/j.schres.2019.10.008_bib49","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/nrn1345","article-title":"Look away: the anti-saccade task and the voluntary control of eye movement","volume":"5","author":"Munoz","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"issue":"3","key":"10.1016\/j.schres.2019.10.008_bib50","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.bandc.2008.08.018","article-title":"Neurophysiology and neuroanatomy of reflexive and volitional saccades as revealed by lesion studies with neurological patients and transcranial magnetic stimulation (TMS)","volume":"68","author":"M\u00fcri","year":"2008","journal-title":"Brain Cogn."},{"issue":"12","key":"10.1016\/j.schres.2019.10.008_bib51","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1001\/archpsyc.1992.01820120063009","article-title":"Schizophrenics show spatial working memory deficits","volume":"49","author":"Park","year":"1992","journal-title":"Arch. Gen. Psychiatr."},{"issue":"3","key":"10.1016\/j.schres.2019.10.008_bib53","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1093\/brain\/114.3.1473","article-title":"Cortical control of reflexive visually-guided saccades","volume":"114","author":"Pierrot-Deseilligny","year":"1991","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.schres.2019.10.008_bib54","first-page":"846","article-title":"Antisaccade performance in schizophrenia patients, their first-degree biological relatives, and community comparison subjects: data from the COGS study","volume":"47","author":"Radant","year":"2010","journal-title":"Psychophysiology"},{"issue":"2","key":"10.1016\/j.schres.2019.10.008_bib70","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.biopsych.2004.10.024","article-title":"Abnormalities in visually guided saccades suggest corticofugal dysregulation in never-treated schizophrenia.","volume":"57","author":"Reilly","year":"2005","journal-title":"Biological Psychiatry"},{"issue":"11","key":"10.1016\/j.schres.2019.10.008_bib55","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1001\/archpsyc.63.11.1189","article-title":"Adverse effects of risperidone on spatial working memory in first-episode schizophrenia","volume":"63","author":"Reilly","year":"2006","journal-title":"Arch. Gen. Psychiatr."},{"issue":"7","key":"10.1016\/j.schres.2019.10.008_bib69","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.biopsych.2006.10.031","article-title":"Antipsychotic drugs exacerbate impairment on a working memory task in first-episode schizophrenia.","volume":"62","author":"Reilly","year":"2007","journal-title":"Biological Psychiatry"},{"issue":"8","key":"10.1016\/j.schres.2019.10.008_bib56","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.biopsych.2007.11.009","article-title":"Reduced attentional engagement contributes to deficits in prefrontal inhibitory control in schizophrenia","volume":"63","author":"Reilly","year":"2008","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2019.10.008_bib57","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.bandc.2008.08.026","article-title":"Pharmacological treatment effects on eye movement control","volume":"68","author":"Reilly","year":"2008","journal-title":"Brain Cogn."},{"issue":"5","key":"10.1016\/j.schres.2019.10.008_bib58","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/schbul\/sbt132","article-title":"Elevated antisaccade error rate as an intermediate phenotype for psychosis across diagnostic categories","volume":"40","author":"Reilly","year":"2014","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2019.10.008_bib59","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2147\/TCRM.S12701","article-title":"Clinical potential of lurasidone in the management of schizophrenia","volume":"7","author":"Samalin","year":"2011","journal-title":"Ther. Clin. Risk Manag."},{"issue":"2","key":"10.1016\/j.schres.2019.10.008_bib60","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1152\/jn.1994.71.2.515","article-title":"The role of D1-dopamine receptor in working memory: local injections of dopamine antagonists into the prefrontal cortex of rhesus monkeys performing an oculomotor delayed-response task","volume":"71","author":"Sawaguchi","year":"1994","journal-title":"J.\u00a0Neurophysiol."},{"issue":"2","key":"10.1016\/j.schres.2019.10.008_bib61","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1152\/jn.1991.66.2.559","article-title":"Neuronal activity related to visually guided saccades in the frontal eye fields of rhesus monkeys: comparison with supplementary eye fields","volume":"66","author":"Schall","year":"1991","journal-title":"J.\u00a0Neurophysiol."},{"issue":"S11","key":"10.1016\/j.schres.2019.10.008_bib62","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1017\/S1092852900025086","article-title":"Atypical antipsychotics: matching receptor profile to individual patient\u2019s clinical profile","volume":"9","author":"Shayegan","year":"2004","journal-title":"CNS Spectr."},{"issue":"S212","key":"10.1016\/j.schres.2019.10.008_bib63","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A\u00a0rating scale for extrapyramidal side effects","volume":"45","author":"Simpson","year":"1970","journal-title":"Acta Psychiatr. Scand."},{"issue":"1","key":"10.1016\/j.schres.2019.10.008_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s004060050058","article-title":"Internally and externally guided voluntary saccades in unmedicated and medicated schizophrenic patients. Part I. Saccadic velocity","volume":"249","author":"Straube","year":"1999","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.schres.2019.10.008_bib65","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3389\/fphar.2013.00102","article-title":"Antipsychotic treatments; focus on lurasidone","volume":"4","author":"Sumiyoshi","year":"2013","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.schres.2019.10.008_bib66","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.schres.2011.09.016","article-title":"Treatment resistant schizophrenia and response to antipsychotics: a review","volume":"133","author":"Suzuki","year":"2011","journal-title":"Schizophr. Res."},{"issue":"7","key":"10.1016\/j.schres.2019.10.008_bib67","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/archpsyc.1988.01800310013001","article-title":"Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia: III. A new cohort and evidence for a monoaminergic mechanism","volume":"45","author":"Weinberger","year":"1988","journal-title":"Arch. Gen. Psychiatr."},{"issue":"7","key":"10.1016\/j.schres.2019.10.008_bib68","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1523\/JNEUROSCI.22-07-02843.2002","article-title":"The physiological role of 5-HT2A receptors in working memory","volume":"22","author":"Williams","year":"2002","journal-title":"J.\u00a0Neurosci."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996419304396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996419304396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:38:30Z","timestamp":1760297910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996419304396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":64,"alternative-id":["S0920996419304396"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2019.10.008","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of high vs. low dose lurasidone on eye movement biomarkers of prefrontal abilities in treatment-resistant schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2019.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}